Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Healthy Participants × Dextromethorphan × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Solid Tumor 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Healthy Participants 1 Advanced Solid Tumor 1 Adult Solid Neoplasm 1

Interventions

Rosuvastatin Calcium 5 capivasertib 2 Digoxin 2 sotorasib 1 ibrutinib 1 Midazolam 1 Dextromethorphan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07241065 2025-11-21

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants

AstraZeneca

Phase 1 Not yet recruiting

Healthy Participants

Data powered by HemOnc (CC BY 4.0) Colophon ⚡